ClinicalTrials.Veeva

Menu

Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases

L

Laval University

Status

Unknown

Conditions

Interstitial Lung Disease

Treatments

Other: Transbronchial lung cryobiopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT02235779
CryobiopsieTBB

Details and patient eligibility

About

Evaluation of diagnostic yield, feasibility and safety of transbronchial lung cryobiopsies done via bronchoscopy in the investigation of interstitial lung disease in comparison with videothoracoscopy-assisted surgical lung biopsy.

Full description

See above

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Volunteer subjects with interstitial lung disease in whom a surgical lung biopsy is planned for diagnostic investigation.

Exclusion criteria

  • Aged less than 18 y.o.
  • Pregnancy
  • Known coagulatoin disorder or blood dyscrasia
  • Aaking antiplatelet agents other than aspirin or therapeutic anticoagulants drugs that cannot be safely discontinued to undergo lung biopsy
  • Arterial oxgen pressure less than 60 mmHg on more than 2 liters per minute oxygen
  • Known pulmonary hypertension defined as systolic PAP above 40 mmHg on echocardiography
  • Unable to provide informed consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Cryobiopsy
Other group
Treatment:
Other: Transbronchial lung cryobiopsy

Trial contacts and locations

1

Loading...

Central trial contact

Antoine Delage, MDCM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems